Mitrade Insights is dedicated to providing investors with rich, timely and most valuable financial information to help investors grasp the market situation and find timely trading opportunities.

2021

Best News & Analysis Provider

FxDailyInfo

2022

Best Forex Educational Resources Global

International Business Magazine

Insights

News

Why Tempus AI Stock Is Skyrocketing Today

Source The Motley Fool

Shares of Tempus AI (NASDAQ: TEM) were skyrocketing 16.5% higher as of 10:39 a.m. ET on Wednesday. The big gain came after the healthcare artificial intelligence (AI) company announced a multiyear partnership with AstraZeneca and Pathos AI to build a multimodal foundation model for cancer drug discovery and development.

Tempus AI has invested heavily over the last decade to create one of the world's largest libraries of multimodal data that can be used in developing precision medicines. The company's de-identified oncology data will be critical in building the foundation model that AstraZeneca hopes to use to accelerate its development of new cancer drugs and increase the chances of success in clinical testing for its candidates.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Learn More »

What this deal means for Tempus AI

Tempus AI will receive $200 million in data licensing and model development fees from AstraZeneca. This amount almost exactly matches the amount of revenue the company generated in the fourth quarter of 2024.

The healthcare AI company will also be able to use the multimodal foundation model it's building in collaboration with AstraZeneca and Pathos AI in its own efforts to improve patient care. This could bode well for Tempus AI's appeal to other big drugmakers seeking to harness the power of AI in their drug development processes.

Is Tempus AI stock a smart pick to buy now?

Risk-averse investors probably should look to other stocks to buy instead of Tempus AI. The company continues to lose money and is difficult to value. However, I think Tempus AI could be a smart pick for aggressive growth investors to buy and hold. The deal with AstraZeneca underscores the promise of its AI platform and data.

Should you invest $1,000 in Tempus Ai right now?

Before you buy stock in Tempus Ai, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Tempus Ai wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $561,046!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $606,106!*

Now, it’s worth noting Stock Advisor’s total average return is 811% — a market-crushing outperformance compared to 153% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.

See the 10 stocks »

*Stock Advisor returns as of April 21, 2025

Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends AstraZeneca Plc. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.

Recommended Articles

Gold edges toward $4,200 as shutdown deal fuels aggressive December Fed cut bets Gold trades near $4,195 in early Asian dealings, brushing up against the $4,200 mark as hopes for a U.S. shutdown-ending funding bill and a nearly 64% market-implied chance of a December Fed rate cut support XAU/USD, even as a divided Federal Reserve and upcoming policymaker speeches threaten to steady the dollar and cap bullion’s latest advance.

Author Mitrade

22 hours ago

Gold trades near $4,195 in early Asian dealings, brushing up against the $4,200 mark as hopes for a U.S. shutdown-ending funding bill and a nearly 64% market-implied chance of a December Fed rate cut support XAU/USD, even as a divided Federal Reserve and upcoming policymaker speeches threaten to steady the dollar and cap bullion’s latest advance.

Why a Quiet 2025 Signals a Massive 2026 Crypto Bull Run: Bitwise CIO Explains Bitwise's Matt Hougan Predicts a Crypto Boom in 2026 Amid Current Market Struggles

Author Mitrade

Yesterday 04: 03

Bitwise's Matt Hougan Predicts a Crypto Boom in 2026 Amid Current Market Struggles

Gold hits three-week top as dovish Fed bets offset US government reopening optimism Gold (XAU/USD) reverses a modest Asian session dip and climbs to an over three-week high, around the $4,213 region, on Thursday.

Author FXStreet

Yesterday 06: 22

Gold (XAU/USD) reverses a modest Asian session dip and climbs to an over three-week high, around the $4,213 region, on Thursday.

Bitcoin vs. Ethereum: Distinct Monetary Universes Bitcoin and Ethereum are diverging significantly in their monetary roles, according to a joint report from Glassnode and Keyrock.

Author Mitrade

3 hours ago

Bitcoin and Ethereum are diverging significantly in their monetary roles, according to a joint report from Glassnode and Keyrock.

Ethereum slides 5% as bears lean on $3,500 cap and put $3,150 support in focus Ethereum (ETH) drops more than 5% after a failed push above $3,550, with price sliding to $3,153 and now holding below $3,350, the 100-hour SMA and a bearish trend line at $3,500; unless bulls reclaim the $3,350–$3,500 zone, the short-term bias stays bearish and a clean break under $3,150 could expose $3,050, $3,000 and even the $2,880–$2,850 support area.

Author Mitrade

2 hours ago

Ethereum (ETH) drops more than 5% after a failed push above $3,550, with price sliding to $3,153 and now holding below $3,350, the 100-hour SMA and a bearish trend line at $3,500; unless bulls reclaim the $3,350–$3,500 zone, the short-term bias stays bearish and a clean break under $3,150 could expose $3,050, $3,000 and even the $2,880–$2,850 support area.

Popular Symbols